MediPharm Labs is a leading brand in the pharmaceutical cannabinoid industry, specializing in the production and manufacturing of high-quality, purified Cannabinoid based derivatives and pharmaceutical ingredients. With a focus on pharma-quality standards, MediPharm Labs brings a trusted pharmaceutical perspective to the cannabis industry. They have obtained the first-of-its-kind Drug Establishment License in North America, allowing them to sell Active Pharmaceutical Ingredients and Pharmaceutical Drug Products to GMP specifications.

MediPharm Labs offers a wide range of products and services, including formulated oils, MCT oil, olive oil, soft chews, and capsules. They ensure that all their products are pure, trusted, and precisely dosable for patients and end consumers. With their global presence and international commercial distribution capabilities, MediPharm Labs aims to provide top-quality cannabis products on a large scale.

In addition to their product offerings, MediPharm Labs is actively involved in research and development, clinical trials, and academic partnerships. They have achieved several certifications, including the Canada and Australia Drug Establishment Licenses, GMP certification, Natural Health Product certification, and more. MediPharm Labs' operations are centered around a 70,000 sq.

They employ advanced extraction techniques, including supercritical CO2 extraction and short-path wiped-film distillation, to produce pharma-quality extracts and concentrates. With a commitment to quality, innovation, and research, MediPharm Labs is dedicated to becoming a trusted global leader in the pharmaceutical cannabinoid industry